1. From the Department of Rheumatology and Clinical Immunology (H.U.) and the Department of Hematology and Oncology (T.O), Clinical Science for Pathological Organs, Kyoto University Graduate School of Medicine, Kyoto, Japan; the Division of Cellular and Gene Therapies (HFM-518), Center for Biologics Evaluation and Research (E.T.B.), Food and Drug Administration, Bethesda, Md; the Department of Medicine, Osaka Dental University (Y.N.), Osaka, Japan; the Department of Microbiology, Kinki University...